ResearcherHumboldt-Universität zu BerlinActive in the last 2 years
Lucas D. Lee
Matched on ORCID iD 0000-0001-5729-0537; OpenAlex author ID A5050387640. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. Co-author DOI 10.1007/s13402-025-01128-8↗
- Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma. Co-author DOI 10.1007/s00411-022-00962-w↗
- Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. Co-author DOI 10.1007/s13402-020-00559-9↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ioannis Pozios · 3 shared papers, 2021–2025 · strength 0.51
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreati… DOI 10.1007/s00411-022-00962-w↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Hendrik Seeliger · 3 shared papers, 2021–2025 · strength 0.51
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreati… DOI 10.1007/s00411-022-00962-w↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Christiane J. Bruns · 3 shared papers, 2021–2025 · strength 0.51
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreati… DOI 10.1007/s00411-022-00962-w↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Peter Čamaj · 2 shared papers, 2021–2025 · strength 0.36
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Nina A. Hering · 2 shared papers, 2021–2025 · strength 0.36
- Paper Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signal… DOI 10.1007/s13402-025-01128-8↗
- Paper Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. DOI 10.1007/s13402-020-00559-9↗
- Katharina Beyer · 1 shared paper, 2022 · strength 0.15
- Carsten Kamphues · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.